NEWS
Oslo Cancer Cluster New leadership in OCC Incubator
A new leadership duo will strengthen OCC Incubator.
Å bekjempe kreft er et historisk oppdrag for Norge
Norge kan redusere tiden for utvikling av ny kreftbehandling fra ti til fem år.
Internationalisation and ethics
Students faced great philosophical questions about vaccine distribution.
Bridging gaps at NLSDays 2021
We participated in the first digital NLSDays this week.
Granted PDT/PCI projects 2021
Radforsk Investment Foundation has granted five research projects…
Innspill til Perspektivmeldingen
Oslo Cancer Cluster har uttalt seg om Perspektivmeldingen 2021.
Lytix Lytix Biopharma and UiT with exclusive agreement
Lytix Biopharma enters into an exclusive license agreement with the Arctic University of Norway (UiT).
Norwegian life science @ SXSW2021
We participated in the influential technology conference SXSW2021.
OCC Accelerator is here
OCC Accelerator will help start-ups in cancer innovation succeed.
